Pharma giants see room for greater tech innovation By LIU ZHIHUA | China Daily | Updated: 2021-03-17 09:10 Share Logo of Bayer Group is pictured outside a plant. [Photo provided to China Daily] China's recently-concluded two sessions have provided a new direction to the development of foreign companies in the country, top executives of leading multinational pharmaceutical companies said. The executives said they are particularly buoyed by the nation's sharpened focus on deeper reforms, wider opening-up, strengthened scientific and technological innovation and the expansion of domestic demand. According to the outline for the 14th Five-Year Plan (2021-25) for economic and social development and long-range objectives through the year 2035, which was passed at the fourth session of the 13th National People's Congress, advancing reform and opening up, pursuing innovation-driven development, creating a robust domestic market and fostering a new dual-circulation development pattern, will prioritize the country's development roadmap.